Literature DB >> 17901988

Identification of a urinary proteomic signature for lupus nephritis in children.

Michiko Suzuki1, Gary F Ross, Kristina Wiers, Shannen Nelson, Michael Bennett, Murray H Passo, Prasad Devarajan, Hermine I Brunner.   

Abstract

The quest for reliable biomarkers of systemic lupus erythematosus (SLE) nephritis is an area of intense contemporary research. In this study, surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology was used for urinary proteomic profiling of patients with SLE nephritis. Clinical, laboratory, and kidney biopsy data from pediatric patients with SLE (n = 32) were analyzed. Children with juvenile idiopathic arthritis (n = 11) served as controls. SELDI-TOF-MS was performed using ProteinChips with different chromatographic surfaces. The resulting spectra were analyzed with Bio-Rad Biomarker Wizard software. A consistent urinary proteomic signature for SLE nephritis was found, comprising eight biomarker proteins with peaks at m/z of 2.7, 22, 23, 44, 56, 79, 100, and 133 kDa. The peak intensities of these biomarkers were significantly greater in patients with SLE nephritis compared with controls and SLE patients without nephritis. These biomarkers were strongly correlated with renal disease activity and moderately with renal damage. For the diagnosis of active nephritis, the area under the receiver operating characteristic curve was > or =0.90 for 22, 23, 44, 79, and 100 kDa biomarkers. Thus, SELDI-TOF-MS has identified a urine proteomic signature strongly associated with SLE renal involvement and active SLE nephritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901988     DOI: 10.1007/s00467-007-0608-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

Authors:  Stefan Schaub; John Wilkins; Tracey Weiler; Kevin Sangster; David Rush; Peter Nickerson
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

2.  Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus.

Authors:  Joel Schiffenbauer; Bevra Hahn; Michael H Weisman; Lee S Simon
Journal:  Arthritis Rheum       Date:  2004-08

3.  Early prediction of acute renal injury using urinary proteomics.

Authors:  Mai T Nguyen; Gary F Ross; Catherine L Dent; Prasad Devarajan
Journal:  Am J Nephrol       Date:  2005-06-16       Impact factor: 3.754

4.  A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.

Authors:  A Ho; S G Barr; L S Magder; M Petri
Journal:  Arthritis Rheum       Date:  2001-10

5.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

6.  Urine biomarkers predict the cause of glomerular disease.

Authors:  Sanju A Varghese; T Brian Powell; Milos N Budisavljevic; Jim C Oates; John R Raymond; Jonas S Almeida; John M Arthur
Journal:  J Am Soc Nephrol       Date:  2007-02-14       Impact factor: 10.121

Review 7.  High throughput proteomic strategies for identifying tumour-associated antigens.

Authors:  C Geeth Gunawardana; Eleftherios P Diamandis
Journal:  Cancer Lett       Date:  2007-02-15       Impact factor: 8.679

8.  Prediction of urinary protein markers in lupus nephritis.

Authors:  Jim C Oates; Sanju Varghese; Alison M Bland; Timothy P Taylor; Sally E Self; Romesh Stanislaus; Jonas S Almeida; John M Arthur
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

9.  Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments.

Authors:  Krishnamurthy P Gudehithlu; Alfredo A Pegoraro; George Dunea; Jose A L Arruda; Ashok K Singh
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

Review 10.  Discovery of protein biomarkers for renal diseases.

Authors:  Stephen M Hewitt; James Dear; Robert A Star
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

View more
  29 in total

1.  Biomarkers of lupus nephritis determined by serial urine proteomics.

Authors:  Xiaolan Zhang; Ming Jin; Haifeng Wu; Tibor Nadasdy; Gyongyi Nadasdy; Nathan Harris; Kari Green-Church; Haikady Nagaraja; Daniel J Birmingham; Chack-Yung Yu; Lee A Hebert; Brad H Rovin
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

Review 2.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

3.  Discovery of SERPINA3 as a candidate urinary biomarker of lupus nephritis activity.

Authors:  Jessica L Turnier; Hermine I Brunner; Michael Bennett; Ashwaq Aleed; Gaurav Gulati; Wendy D Haffey; Sherry Thornton; Michael Wagner; Prasad Devarajan; David Witte; Kenneth D Greis; Bruce Aronow
Journal:  Rheumatology (Oxford)       Date:  2019-02-01       Impact factor: 7.580

4.  urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Jason G Lieberthal; David Cuthbertson; Simon Carette; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Kathleen Maksimowicz-McKinnon; Philip Seo; Ulrich Specks; Steven R Ytterberg; Peter A Merkel; Paul A Monach
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

5.  Using proteomics to identify preprocedural risk factors for contrast induced nephropathy.

Authors:  Michael R Bennett; Neelima Ravipati; Gary Ross; Mai T Nguyen; Russel Hirsch; Robert H Beekman; Leon Rovner; Prasad Devarajan
Journal:  Proteomics Clin Appl       Date:  2008       Impact factor: 3.494

Review 6.  Biomarkers for renal disease in childhood.

Authors:  Lena Das; Hermine I Brunner
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

7.  Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis.

Authors:  Michiko Suzuki; Kristina Wiers; Elizabeth B Brooks; Kenneth D Greis; Kathleen Haines; Marisa S Klein-Gitelman; Judyann Olson; Karen Onel; Kathleen M O'Neil; Earl D Silverman; Lori Tucker; Jun Ying; Prasad Devarajan; Hermine I Brunner
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

Review 8.  Biomarkers for lupus nephritis: a critical appraisal.

Authors:  Chi Chiu Mok
Journal:  J Biomed Biotechnol       Date:  2010-04-19

9.  Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.

Authors:  Anders Carlsson; Dirk M Wuttge; Johan Ingvarsson; Anders A Bengtsson; Gunnar Sturfelt; Carl A K Borrebaeck; Christer Wingren
Journal:  Mol Cell Proteomics       Date:  2011-02-24       Impact factor: 5.911

10.  Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.

Authors:  Claas H Hinze; Michiko Suzuki; Marisa Klein-Gitelman; Murray H Passo; Judyann Olson; Nora G Singer; Kathleen A Haines; Karen Onel; Kathleen O'Neil; Earl D Silverman; Lori Tucker; Jun Ying; Prasad Devarajan; Hermine I Brunner
Journal:  Arthritis Rheum       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.